Navigation Links
Study Finds Broadband Access Key to Empowerment of Minority Communities
Date:3/11/2008

Local Council Formed to Study Impact on Detroit Area

DETROIT, March 11 /PRNewswire/ -- Today, The Alliance for Digital Equality announced findings from its new study, Affordable Broadband: Empowering Communities Across the Digital Divide, which examines how broadband has expanded access to education, health care and civic involvement in minority communities. Additionally, The Alliance formally introduced the Detroit Digital Empowerment Council (DEC) that was launched earlier this year to examine the impact of broadband on the local community. The Detroit DEC is part of The Alliance's nationwide initiative that advocates for increased broadband access -- especially in urban and underserved communities. Previously, The Alliance has launched Councils in Charleston, South Carolina and Houston, Texas.

"For those individuals with access to broadband and other cutting-edge technologies, unprecedented opportunity is available," said Julius H. Hollis, chairman of The Alliance for Digital Equality. "It is the goal of The Alliance to become the voice of underserved communities and to ensure that broadband remains affordable so that the newest online users have continued access and that the last ones on aren't the first ones off."

"Broadband affords Americans opportunities to benefit from new technologies and progress in areas such as education and healthcare," said Dr. Earlexia Norwood of Henry Ford Health Systems and the Detroit DEC Chairperson. "Access to new technologies can open the door to life-saving solutions and fundamentally change the way we deliver health care." The Detroit Digital Empowerment Council will be one of many nationwide efforts by The Alliance to bring together community leaders who can provide keen insight and direction to improve digital empowerment opportunities for all citizens.

Broadband internet access helps create wealth and opportunity for communities that are wired. The study found that while there rema
'/>"/>

SOURCE The Alliance for Digital Equality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
2. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
3. Fralex reaches 100th patient milestone in fibromyalgia study
4. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
5. Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
6. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
7. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
8. New Independent Research Study Indicates That Cylexs ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
9. New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans
10. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
11. Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: N...today that the company will be presenting at the 2... 2, 2009 at 12:30 pm local time at The New York Pa...of the company,s business strategy, research and d...nk to the live audio only presentation can be acce...
(Date:11/30/2009)...0 Biopharmaceutical company Kiadis...ve been enrolled in its,multinational registration...ed to show reduction in transplant related mortali...em cell transplantation with a mismatched,(haplo-i...for an allogeneic,stem cell transplantation but wi...
(Date:11/30/2009)...d LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/...tin Board: CYXN; ,China Yongxin,Pharmaceuticals, o...tor and,retailer of pharmaceuticals in Northeaster...ion for distribution of medicines on the Essential...ntly formalized the nation,s Essential Drug,List w...
(Date:11/30/2009)...Newswire-FirstCall/ -- BioMarin Pharmaceutical Inc...nd Drug Administration (FDA) has granted orphan dr...amifampridine phosphate, for the rare autoimmune d...3,4-DAP has previously received orphan drug design...ittee for Medicinal Products for Human Use of the ...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4
...sedly a banner year for venture capital investment...ers MoneyTree report, which is based on data from ... what does this mean for the life science industry... more particularly, what does it mean for the Midw...rill down to this level and find out (I can hear t...
... it again. He,s making sensational, not entirely a...business based on current conditions, which is nic...rd Business Review published an article by Carr ti...s that IT is now ubiquitous and available to all w...inable competitive advantage. , ,Even discounting ...
...ring we just escaped January a notoriously depres... the cold, dark and dank weather thats no surpris...t January 24 (just one week ago) was the most depr...reneurs already bear an extra psychological burden...sion might have escalated last month for reasons t...
Other Biology Technology:Life-science sector grabbed VC investment in 2004 2Life-science sector grabbed VC investment in 2004 3Whining should not get in the way of innovation 2Whining should not get in the way of innovation 3Post-January, tech entrepreneurs have reasons to be depressed 2Post-January, tech entrepreneurs have reasons to be depressed 3Post-January, tech entrepreneurs have reasons to be depressed 4
(Date:11/30/2009)...ity of Pittsburgh team overcame a major hurdle pla...se that could lead to more efficient catalysts use...toxic. The researchers reported Nov. 29 in Nature...ature stability in metallic nanoparticles, the vau...rability to extreme heat. , Gtz Veser, an associ...
(Date:11/30/2009)... Journal of Experimental Biology are pleased to a... de la Recherche Scientifique (CNRS) in the Univer... year,s JEB Outstanding Paper Prize. ,The prize ...ement and is intended to encourage young scientist..., and adds that ,we truly appreciate when authors ...
(Date:11/30/2009)...ower early bird registration rates and register on... 2010 at http://www.iofwco-ecceo10.org/ , WHA...rnational Osteoporosis Foundation (IOF) and the Eu...f Osteoporosis and Osteoarthritis (ESCEO). More th...pected to attend. The exciting scientific programm...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 1Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 2Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 3Second Generation Female Condom is Now Available in the United States 3B FC2 Female Condom Will Cost 30 Percent Less than Predecessor 5154 4Health Strategies Group Introduces Oncology Performance Edge 5150 1Health Strategies Group Introduces Oncology Performance Edge 5150 2Health Strategies Group Introduces Oncology Performance Edge 5150 3Scientists decipher missing piece of first responder DNA repair machine 58671 1Scientists decipher missing piece of first responder DNA repair machine 58671 2Scientists decipher missing piece of first responder DNA repair machine 58671 3
...w vaccine aimed at preventing cervical cancer is n...of the human papillomavirus (HPV) responsible for ...wide study of the vaccine will be published in the...e. , Cervical cancer is the second most common cau...in nearly half a million diagnoses and 240,000 dea...
...scientific evidence is helping to build a compelli...adjunctive treatment for many cancers. , Reovir...lgary, Alberta-based Oncolytics Biotech, has shown...mor cells, in animal models, and in human clinical...ion, Reolysin®, is active against numerous cancers...
...archers at UNIVET, a spin-off of the Universitat A...al nutrition company Affinity Petcare, have develo...reproduces the characteristics of dog’s skin and w...rious lines of research related to skin biology an..., The basic structure of skin consists of an exter...
Other Biology News:Study shows continued success for new HPV vaccine against virus responsible for cervical cancer 2Dealing deadly cancers a knockout punch 2Dealing deadly cancers a knockout punch 3
Tricyclic Antidepressents ELISA Kit, Single from Bio-Quant Inc.
VZV IgM ELISA Kit, Single from Bio-Quant Inc.
Scion Image for Windows from Scion Corporation
...mbion's custom siRNA service provides the premium ...search. Custom siRNAs can be readily ordered onlin...ce, or by providing the sense and antisense siRNA ...ated and Silencer Pre-designed siRNAs, which are a...
Biology Products: